🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,469

Quick answer

1,469 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7923001

    Compositions and methods for diagnosing and treating urinary tract infections

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7910587

    Quinoxalinyl dipeptide hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7906513

    Hydrazide-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7902148

    Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

    Theravance, Inc. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7901921

    Viral purification methods

    ONCOLYTICS BIOTECH INC. · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7897152

    Viral chemokine-antigen fusion proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7892567

    Methods and compositions for immunization against chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7875598

    Compositions useful for the treatment of microbial infections

    The Regents of the University of California · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7872110

    Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection

    United Biomedical, Inc. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7867476

    Method and materials for use in diagnosing viral myocarditis

    The Regents of the University of California · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7868162

    Antimicrobial and antiviral compounds and methods for their use

    Lakewood Amedex, Inc. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7850970

    Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections

    The Regents of the University of Colorado · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7846454

    Cloned genomes of infectious hepatitis C viruses and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7833533

    Enhanced antiviral activity against foot and mouth disease

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7825136

    Potentiators of antibacterial activity

    Vertex Pharmaceuticals Incorporated · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7820631

    Anti-viral pyrimidine nucleoside analogues

    University College Cardiff Consultants Limited · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7807179

    Modified reoviral therapy

    The Board of Regents of the University of Texas System · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7807781

    Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections

    The Regents of the University of Colorado · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7790159

    Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7790181

    Live attenuated viral vaccines for Eastern Equine Encephalitis virus

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7781478

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7776847

    Benzisothiazoles useful for treating or preventing HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7777000

    Anti-viral activity of cathelicidin peptides

    The Regents of the University of California · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7776883

    Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7776337

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7772271

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7771729

    Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7763259

    Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

    The Regents of the University of Colorado · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7758876

    Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7754420

    Methods of using cyanovirins to inhibit viral infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7749983

    Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates

    The Regents of the University of California · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7745418

    Compositions and methods for inhibiting viral replication

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7740889

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7737124

    Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

    The Regents of the University of California · Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7732207

    Method for expression of small antiviral RNA molecules within a cell

    The Regents of the University of California · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7731971

    Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7727970

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted to Hepatitis C virus

    Benitec, Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7728148

    Acyclic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7718769

    Tri-peptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7718612

    Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7718183

    Proteins with repetitive bacterial-Ig-like (big) domains present in Leptospira species

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7718610

    Retrocyclins: antiviral and antimicrobial peptides

    The Regents of the University of California · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7713529

    Methods for treating and preventing infectious disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7714137

    Pyridyl substituted heterocycles useful for treating or preventing HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7704976

    Use of N-acetyl-D-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention

    Third Military Medical University, Chinese People's Liberation Army, P.R. of China · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7700273

    Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human immunodeficiency virus (HIV) CCR5 coreceptor

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7687459

    Arylalkoxyl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7678569

    Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Infectious disease patents are indexed?

1,469 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.